+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05155878

Study of Prognostic Factors and Surgical Outcomes for Pancreas and Periampullary Tumors and Cysts

Led by Umeå University · Updated on 2022-01-05

500

Participants Needed

1

Research Sites

260 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are conducting an observational study to analyze factors that predict outcomes and guide diagnosis and surgical treatment for cysts and tumors in the pancreas and periampullary area. This research uses clinical data along with blood and tissue samples to develop and validate biomarkers. The study includes both retrospective enrollment and prospective enrollment starting from November 2021, aiming to understand clinical outcomes and prognostic factors based on patient and tumor characteristics. Participants recommended for surgery due to tumors or cysts in the pancreas or periampullary region are included in this study. The research involves collecting and reviewing electronic medical records and biological samples. There are no specific treatment groups or interventions, as the study observes and records outcomes over time. During the study, participants clinical data and surgical outcomes are monitored, focusing on overall survival over 10 years as the primary measure. Secondary outcomes include complication rates and the extent of tumor removal radical resection over the same period. The study includes both living participants who provide consent and retrospective data from deceased individuals. The long-term follow-up offers insights into surgical care and outcomes for these conditions.

CONDITIONS

Brief Title

Prognostic Factors in Periampullary Tumors and Cysts

Research Team

O

Oskar Franklin, MD/PhD

A

Asif Halimi, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here